(Total Views: 484)
Posted On: 05/04/2020 12:42:51 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: reallypeople? #31925
Quote:
The modified protocol is a Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Leronlimab in Patients with Coronavirus Disease 2019 (COVID-19) and calls for 75 planned patients in up to 10 centers in the United States. Patients enrolled in the trial are expected to have a treatment window of approximately 6 weeks.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)